12 recombinant mouse il 23 protein r d system Search Results


dapi ebioscience 00 4959 52 trypsin versene lonza 17 161f recombinant mouse bmp 4 protein r d 5020 bp 010 poly l lysine sigma p8920  (Thermo Fisher)
99
Thermo Fisher dapi ebioscience 00 4959 52 trypsin versene lonza 17 161f recombinant mouse bmp 4 protein r d 5020 bp 010 poly l lysine sigma p8920
Dapi Ebioscience 00 4959 52 Trypsin Versene Lonza 17 161f Recombinant Mouse Bmp 4 Protein R D 5020 Bp 010 Poly L Lysine Sigma P8920, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dapi ebioscience 00 4959 52 trypsin versene lonza 17 161f recombinant mouse bmp 4 protein r d 5020 bp 010 poly l lysine sigma p8920/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
dapi ebioscience 00 4959 52 trypsin versene lonza 17 161f recombinant mouse bmp 4 protein r d 5020 bp 010 poly l lysine sigma p8920 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
recombinant mouse il 6 protein r d systems  (R&D Systems)
96
R&D Systems recombinant mouse il 6 protein r d systems
Recombinant Mouse Il 6 Protein R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse il 6 protein r d systems/product/R&D Systems
Average 96 stars, based on 1 article reviews
recombinant mouse il 6 protein r d systems - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
9806s recombinant human integrin alpha v beta 1 protein  (Cell Signaling Technology Inc)
99
Cell Signaling Technology Inc 9806s recombinant human integrin alpha v beta 1 protein
9806s Recombinant Human Integrin Alpha V Beta 1 Protein, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/9806s recombinant human integrin alpha v beta 1 protein/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
9806s recombinant human integrin alpha v beta 1 protein - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
human shh protein  (R&D Systems)
95
R&D Systems human shh protein
Figure 7. Partial Rescue of Cell Defects by <t>Shh</t> in BRG1-Deficient Human Bulge Cells (A–D) Growth of human bulge cells 48 hr <t>after</t> <t>doxycycline</t> (Dox) treatment and siCtrl (A and C) or siBRG1 (B and D) infection in the absence (A and B) or presence (C and D) of human recombinant SHH (rSHH). (E–H) BrdU incorporation of human bulge cells 48 hr after Dox treatment and siCtrl (E and G) or siBRG1 (F and H) infection in the absence (E and F) or presence (G and H) of rSHH. Arrows indicate BrdU-positive cells. (I) Quantification of BrdU incorporation in siCtrl ± rSHH and siBRG1 ± rSHH groups. (J and K) Quantitation of BRG1 and p27Kip1
Human Shh Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human shh protein/product/R&D Systems
Average 95 stars, based on 1 article reviews
human shh protein - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
materials recombinant mouse resistin protein  (R&D Systems)
94
R&D Systems materials recombinant mouse resistin protein
Figure 7. Partial Rescue of Cell Defects by <t>Shh</t> in BRG1-Deficient Human Bulge Cells (A–D) Growth of human bulge cells 48 hr <t>after</t> <t>doxycycline</t> (Dox) treatment and siCtrl (A and C) or siBRG1 (B and D) infection in the absence (A and B) or presence (C and D) of human recombinant SHH (rSHH). (E–H) BrdU incorporation of human bulge cells 48 hr after Dox treatment and siCtrl (E and G) or siBRG1 (F and H) infection in the absence (E and F) or presence (G and H) of rSHH. Arrows indicate BrdU-positive cells. (I) Quantification of BrdU incorporation in siCtrl ± rSHH and siBRG1 ± rSHH groups. (J and K) Quantitation of BRG1 and p27Kip1
Materials Recombinant Mouse Resistin Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/materials recombinant mouse resistin protein/product/R&D Systems
Average 94 stars, based on 1 article reviews
materials recombinant mouse resistin protein - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
recombinant pdgf bb protein  (R&D Systems)
92
R&D Systems recombinant pdgf bb protein
Figure 7. Partial Rescue of Cell Defects by <t>Shh</t> in BRG1-Deficient Human Bulge Cells (A–D) Growth of human bulge cells 48 hr <t>after</t> <t>doxycycline</t> (Dox) treatment and siCtrl (A and C) or siBRG1 (B and D) infection in the absence (A and B) or presence (C and D) of human recombinant SHH (rSHH). (E–H) BrdU incorporation of human bulge cells 48 hr after Dox treatment and siCtrl (E and G) or siBRG1 (F and H) infection in the absence (E and F) or presence (G and H) of rSHH. Arrows indicate BrdU-positive cells. (I) Quantification of BrdU incorporation in siCtrl ± rSHH and siBRG1 ± rSHH groups. (J and K) Quantitation of BRG1 and p27Kip1
Recombinant Pdgf Bb Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant pdgf bb protein/product/R&D Systems
Average 92 stars, based on 1 article reviews
recombinant pdgf bb protein - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
recombinant mouse gas6 gas6 protein  (R&D Systems)
93
R&D Systems recombinant mouse gas6 gas6 protein
Figure 7. Partial Rescue of Cell Defects by <t>Shh</t> in BRG1-Deficient Human Bulge Cells (A–D) Growth of human bulge cells 48 hr <t>after</t> <t>doxycycline</t> (Dox) treatment and siCtrl (A and C) or siBRG1 (B and D) infection in the absence (A and B) or presence (C and D) of human recombinant SHH (rSHH). (E–H) BrdU incorporation of human bulge cells 48 hr after Dox treatment and siCtrl (E and G) or siBRG1 (F and H) infection in the absence (E and F) or presence (G and H) of rSHH. Arrows indicate BrdU-positive cells. (I) Quantification of BrdU incorporation in siCtrl ± rSHH and siBRG1 ± rSHH groups. (J and K) Quantitation of BRG1 and p27Kip1
Recombinant Mouse Gas6 Gas6 Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse gas6 gas6 protein/product/R&D Systems
Average 93 stars, based on 1 article reviews
recombinant mouse gas6 gas6 protein - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
7666 mb  (R&D Systems)
96
R&D Systems 7666 mb
Figure 7. Partial Rescue of Cell Defects by <t>Shh</t> in BRG1-Deficient Human Bulge Cells (A–D) Growth of human bulge cells 48 hr <t>after</t> <t>doxycycline</t> (Dox) treatment and siCtrl (A and C) or siBRG1 (B and D) infection in the absence (A and B) or presence (C and D) of human recombinant SHH (rSHH). (E–H) BrdU incorporation of human bulge cells 48 hr after Dox treatment and siCtrl (E and G) or siBRG1 (F and H) infection in the absence (E and F) or presence (G and H) of rSHH. Arrows indicate BrdU-positive cells. (I) Quantification of BrdU incorporation in siCtrl ± rSHH and siBRG1 ± rSHH groups. (J and K) Quantitation of BRG1 and p27Kip1
7666 Mb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/7666 mb/product/R&D Systems
Average 96 stars, based on 1 article reviews
7666 mb - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
recombinant mouse neurocan protein  (R&D Systems)
94
R&D Systems recombinant mouse neurocan protein
Figure 7. Partial Rescue of Cell Defects by <t>Shh</t> in BRG1-Deficient Human Bulge Cells (A–D) Growth of human bulge cells 48 hr <t>after</t> <t>doxycycline</t> (Dox) treatment and siCtrl (A and C) or siBRG1 (B and D) infection in the absence (A and B) or presence (C and D) of human recombinant SHH (rSHH). (E–H) BrdU incorporation of human bulge cells 48 hr after Dox treatment and siCtrl (E and G) or siBRG1 (F and H) infection in the absence (E and F) or presence (G and H) of rSHH. Arrows indicate BrdU-positive cells. (I) Quantification of BrdU incorporation in siCtrl ± rSHH and siBRG1 ± rSHH groups. (J and K) Quantitation of BRG1 and p27Kip1
Recombinant Mouse Neurocan Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse neurocan protein/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant mouse neurocan protein - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
recombinant human lap  (R&D Systems)
94
R&D Systems recombinant human lap
Figure 7. Partial Rescue of Cell Defects by <t>Shh</t> in BRG1-Deficient Human Bulge Cells (A–D) Growth of human bulge cells 48 hr <t>after</t> <t>doxycycline</t> (Dox) treatment and siCtrl (A and C) or siBRG1 (B and D) infection in the absence (A and B) or presence (C and D) of human recombinant SHH (rSHH). (E–H) BrdU incorporation of human bulge cells 48 hr after Dox treatment and siCtrl (E and G) or siBRG1 (F and H) infection in the absence (E and F) or presence (G and H) of rSHH. Arrows indicate BrdU-positive cells. (I) Quantification of BrdU incorporation in siCtrl ± rSHH and siBRG1 ± rSHH groups. (J and K) Quantitation of BRG1 and p27Kip1
Recombinant Human Lap, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human lap/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant human lap - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
recombinant mouse prolactin protein  (R&D Systems)
94
R&D Systems recombinant mouse prolactin protein
Figure 7. Partial Rescue of Cell Defects by <t>Shh</t> in BRG1-Deficient Human Bulge Cells (A–D) Growth of human bulge cells 48 hr <t>after</t> <t>doxycycline</t> (Dox) treatment and siCtrl (A and C) or siBRG1 (B and D) infection in the absence (A and B) or presence (C and D) of human recombinant SHH (rSHH). (E–H) BrdU incorporation of human bulge cells 48 hr after Dox treatment and siCtrl (E and G) or siBRG1 (F and H) infection in the absence (E and F) or presence (G and H) of rSHH. Arrows indicate BrdU-positive cells. (I) Quantification of BrdU incorporation in siCtrl ± rSHH and siBRG1 ± rSHH groups. (J and K) Quantitation of BRG1 and p27Kip1
Recombinant Mouse Prolactin Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse prolactin protein/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant mouse prolactin protein - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
recombinant mouse tweak protein  (R&D Systems)
94
R&D Systems recombinant mouse tweak protein
Figure 7. Partial Rescue of Cell Defects by <t>Shh</t> in BRG1-Deficient Human Bulge Cells (A–D) Growth of human bulge cells 48 hr <t>after</t> <t>doxycycline</t> (Dox) treatment and siCtrl (A and C) or siBRG1 (B and D) infection in the absence (A and B) or presence (C and D) of human recombinant SHH (rSHH). (E–H) BrdU incorporation of human bulge cells 48 hr after Dox treatment and siCtrl (E and G) or siBRG1 (F and H) infection in the absence (E and F) or presence (G and H) of rSHH. Arrows indicate BrdU-positive cells. (I) Quantification of BrdU incorporation in siCtrl ± rSHH and siBRG1 ± rSHH groups. (J and K) Quantitation of BRG1 and p27Kip1
Recombinant Mouse Tweak Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse tweak protein/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant mouse tweak protein - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


Figure 7. Partial Rescue of Cell Defects by Shh in BRG1-Deficient Human Bulge Cells (A–D) Growth of human bulge cells 48 hr after doxycycline (Dox) treatment and siCtrl (A and C) or siBRG1 (B and D) infection in the absence (A and B) or presence (C and D) of human recombinant SHH (rSHH). (E–H) BrdU incorporation of human bulge cells 48 hr after Dox treatment and siCtrl (E and G) or siBRG1 (F and H) infection in the absence (E and F) or presence (G and H) of rSHH. Arrows indicate BrdU-positive cells. (I) Quantification of BrdU incorporation in siCtrl ± rSHH and siBRG1 ± rSHH groups. (J and K) Quantitation of BRG1 and p27Kip1

Journal: Developmental cell

Article Title: Brg1 governs a positive feedback circuit in the hair follicle for tissue regeneration and repair.

doi: 10.1016/j.devcel.2013.03.015

Figure Lengend Snippet: Figure 7. Partial Rescue of Cell Defects by Shh in BRG1-Deficient Human Bulge Cells (A–D) Growth of human bulge cells 48 hr after doxycycline (Dox) treatment and siCtrl (A and C) or siBRG1 (B and D) infection in the absence (A and B) or presence (C and D) of human recombinant SHH (rSHH). (E–H) BrdU incorporation of human bulge cells 48 hr after Dox treatment and siCtrl (E and G) or siBRG1 (F and H) infection in the absence (E and F) or presence (G and H) of rSHH. Arrows indicate BrdU-positive cells. (I) Quantification of BrdU incorporation in siCtrl ± rSHH and siBRG1 ± rSHH groups. (J and K) Quantitation of BRG1 and p27Kip1

Article Snippet: Rescue Experiments with Recombinant Human SHH Proteins and Lentivirus-Expressing SHH The siCtrl and siBrg1 bulge cells were treated with/without doxycycline and with/without 1 mg/ml active form of recombinant human SHH protein (R&D Systems) for 48 hr before analysis.

Techniques: Infection, Recombinant, BrdU Incorporation Assay, Quantitation Assay